register

ESG

Pfizer spotlights ‘being a good corporate citizen’ in its 175th year of operations

Health Industry Hub | March 27, 2024 |

ESG: In its latest Impact Report, Pfizer has highlighted the company’s multifaceted approach to reducing its environmental footprint, promoting social wellbeing, and upholding strong governance standards.

“As Pfizer embarks on our 175th year of operations as one of the world’s most trusted and innovative healthcare companies, we are determined to outdo yesterday by remaining committed not only to advancing our purpose, but to being a good corporate citizen,” stated Dr Albert Bourla, Pfizer’s Chairman and CEO.

Anne Harris, Managing Director of Pfizer Australia & New Zealand, expressed pride in the company’s dedication to addressing societal challenges locally.

“I am proud of Pfizer’s commitment to tackling the challenges that face our society through initiatives that support a number of underserved and vulnerable communities around the world.”

She added “Locally, our employees embody the organisation’s values of excellence, equity, courage and joy, by participating in volunteering opportunities, fundraising activities and partnerships with our charities of choice, including The Smith Family in Australia. We also remain committed to our reconciliation journey of cultural awareness and have been investing deliberately in community programs that help close the gap.”

In the fiscal year of 2023, Pfizer announced global revenues of $58.5 billion. This figure represents an operational decline of 41% compared to the previous year, largely attributable to a significant reduction in revenues from its COVID-19 products. However, when excluding the revenues generated from these products, the company achieved a 7% operational revenue growth, aligning with its projections for non-COVID-19 product revenues. This included approximately $120 million in revenue from Seagen, following its acquisition in December.

In addition to expanding access to medicines, and creating opportunities to advance DE&I, Pfizer emphasised its efforts to reduce its environmental footprint and contribute to a healthier planet.

The company achieved a milestone in 2023, with a 13.9% reduction in Scope 1 & 2 Greenhouse Gas (GHG) emissions compared to the 2019 baseline. This reduction aligns with Pfizer’s ambitious goal of reaching the Net Zero Standard by 2040 and decrease its company GHG emissions by 95% and its value chain emissions by 90% from 2019 levels.

“We take seriously our obligation to conduct ourselves in a way that makes the world a better place. Discovering, manufacturing, and delivering innovative vaccines and medicines is only part of what we contribute to society,” highlighted Dr Bourla. “This Impact Report and our accomplishments give me great pride. I am excited about what we will accomplish going forward.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Clinical and Laboratory Haematologist and Lead of the Molecular Haematology Service

Clinicians call for closer monitoring of patients post CAR T therapy

Health Industry Hub | February 17, 2025 |

Australian clinicians are raising questions about whether cancer patients need closer monitoring after receiving CAR T-cell therapy. A Peter MacCallum […]

More


News & Trends - MedTech & Diagnostics

Next-gen surgical mesh to fill critical gap after ban

Next-gen surgical mesh to fill critical gap after regulatory ban

Health Industry Hub | February 17, 2025 |

Next-generation urogynaecological surgical mesh implants are on the horizon for women suffering from pelvic organ prolapse (POP). This development aims […]

More


News & Trends - Pharmaceuticals

Contraceptive lawsuit against Bayer fails

Contraceptive lawsuit against Bayer fails

Health Industry Hub | February 17, 2025 |

The Victorian Supreme Court has dismissed a class action against Bayer for an allegedly defective contraceptive device. Justice Andrew Keogh […]

More


News & Trends - Pharmaceuticals

NSW Government ignored warnings since 2018: Mental health system unravels as psychiatrists quit en masse

NSW Government ignored warnings since 2018: Mental health system unravels as psychiatrists quit en masse

Health Industry Hub | February 17, 2025 |

The New South Wales Labor government’s plan to “redesign” the state’s mental health system, while excluding psychiatrists, has sparked intense […]

More


This content is copyright protected. Please subscribe to gain access.